You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

ARGININE HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for arginine hydrochloride and what is the scope of patent protection?

Arginine hydrochloride is the generic ingredient in one branded drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for arginine hydrochloride. One supplier is listed for this compound.

Summary for ARGININE HYDROCHLORIDE
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 3
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 145
Clinical Trials: 370
Patent Applications: 6,932
What excipients (inactive ingredients) are in ARGININE HYDROCHLORIDE?ARGININE HYDROCHLORIDE excipients list
DailyMed Link:ARGININE HYDROCHLORIDE at DailyMed
Recent Clinical Trials for ARGININE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Yusuf MendaEarly Phase 1
Holden Comprehensive Cancer CenterEarly Phase 1
National Jewish HealthPhase 2

See all ARGININE HYDROCHLORIDE clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for ARGININE HYDROCHLORIDE

US Patents and Regulatory Information for ARGININE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn R-GENE 10 arginine hydrochloride INJECTABLE;INJECTION 016931-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

ARGININE HYDROCHLORIDE Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Arginine Hydrochloride

Market Overview

Arginine hydrochloride, a form of the amino acid L-arginine, is a crucial component in various industries, including pharmaceuticals, nutrition, and sports nutrition. The market for arginine hydrochloride is driven by its multiple health benefits and increasing demand from health-conscious consumers.

Market Size and Growth

The global arginine market, which includes arginine hydrochloride, is projected to experience significant growth. Here are some key statistics:

  • The global arginine market is expected to reach 39 thousand tons by 2032, growing at a CAGR of 5.51% from 2023 to 2032[1].
  • The L-arginine supplements market, a subset of the broader arginine market, was valued at USD 452.1 million in 2023 and is anticipated to grow at a CAGR of 8.7% from 2024 to 2030, reaching USD 807.6 million by 2030[3].

End-Use Segments

The demand for arginine hydrochloride is driven by several end-use segments:

  • Nutrition and Supplements: This segment is leading the global arginine market. L-arginine supplements are popular for their role in cardiovascular health, muscle recovery, and immune support[1][3][4].
  • Pharmaceuticals: Arginine hydrochloride is used in various pharmaceutical applications, including the treatment of conditions such as peripheral arterial disease and angina[4].
  • Sports Nutrition: The amino acid is widely used in sports nutrition products to enhance oxygen delivery to muscles, improve athletic performance, and aid in muscle recovery[3][4].
  • Cosmetics and Personal Care: There is a growing interest in the use of L-arginine in the cosmetics and personal care industry due to its benefits in skin health and other applications[4].

Regional Outlook

The market for arginine hydrochloride is geographically diverse, with different regions contributing significantly:

  • Asia Pacific: This region is expected to dominate the global arginine market during the forecast period, driven by the shift towards preventive healthcare and the rise in fitness centers and sporting activities[1][3][4].
  • North America: This region holds a significant share in the L-arginine supplements market, driven by a strong consumer focus on health and wellness. The U.S. market, in particular, is expected to grow at a significant CAGR from 2024 to 2030[3][4].
  • Europe: Europe is another key region, with growing healthcare spending and significant growth in the pharmaceutical industry contributing to the demand for L-arginine[4].

Key Players

The market for arginine hydrochloride is competitive, with several key players:

  • Ajinomoto Co., Inc.
  • Kyowa Hakko Bio Co., Ltd.
  • CJ CheilJedang Corporation
  • Evonik Industries AG
  • Sichuan Tongsheng Amino Acid Co., Ltd.
  • Daesang Corporation
  • Meihua Group
  • Jingjing Pharmaceutical Co., Ltd.
  • Novus International, Inc.
  • **Shine Star (Hubei) Biological Engineering Co., Ltd.[1][4].

Market Drivers

Several factors are driving the growth of the arginine hydrochloride market:

  • Growing Health Consciousness: Increasing awareness of the health benefits of L-arginine, such as cardiovascular health, immune support, and athletic performance, is driving demand[3][4].
  • Sports and Fitness Trends: The global trend towards bodybuilding and fitness is significantly boosting the demand for L-arginine supplements[4].
  • Pharmaceutical Applications: The use of arginine hydrochloride in treating various health conditions is another key driver[4].

Market Restraints

Despite the growth, there are some challenges facing the market:

  • Price Competition: The market is highly competitive, with price being a significant factor. This competition can affect profit margins and market growth[4].

Financial Trajectory

The financial outlook for the arginine hydrochloride market is positive:

  • The global L-arginine market was valued at USD 23.3 billion in 2022 and is expected to grow to USD 46.1 billion by 2031, indicating a robust financial trajectory[4].
  • The L-arginine supplements market, specifically, is expected to grow from USD 452.1 million in 2023 to USD 807.6 million by 2030, reflecting a CAGR of 8.7%[3].

Distribution Channels

The distribution channels for arginine hydrochloride and its supplements are diverse:

  • Hypermarkets/Supermarkets
  • Pharmacies
  • Specialty Stores
  • Online Channels[3].

Product Forms

Arginine hydrochloride is available in various forms to cater to different consumer preferences:

  • Capsules & Tablets
  • Liquid
  • Powder[3].

Conclusion and Future Outlook

The market for arginine hydrochloride is poised for significant growth driven by its health benefits, increasing demand from the sports and fitness sector, and expanding pharmaceutical applications. As health consciousness continues to rise globally, the demand for L-arginine supplements is expected to increase, driving the market forward.

Key Takeaways

  • The global arginine market is projected to grow at a CAGR of 5.51% from 2023 to 2032.
  • The L-arginine supplements market is expected to grow at a CAGR of 8.7% from 2024 to 2030.
  • The nutrition and supplements segment is leading the global arginine market.
  • Asia Pacific is expected to dominate the global arginine market during the forecast period.
  • Key players include Ajinomoto Co., Inc., Kyowa Hakko Bio Co., Ltd., and Evonik Industries AG.
  • Growing health consciousness and sports and fitness trends are major market drivers.

FAQs

1. What is the projected CAGR of the global arginine market?

The global arginine market is expected to rise at a CAGR of 5.51% during the forecast period from 2023 to 2032[1].

2. Which segment is leading the global arginine market?

The nutrition and supplements segment is leading the global arginine market[1].

3. What are the primary health benefits of L-arginine supplements?

L-arginine supplements are known for their benefits in cardiovascular health, muscle recovery, and immune support[3][4].

4. Which region is expected to dominate the global arginine market?

Asia Pacific is likely to dominate the global arginine market during the forecast period[1][3][4].

5. What is the expected market size of the L-arginine supplements market by 2030?

The L-arginine supplements market is expected to reach USD 807.6 million by 2030[3].

Sources:

  1. ChemAnalyst: Arginine Market Size, Growth, Analysis & Forecast, 2032
  2. Sigma-Aldrich: L -Arginine-15N4 15N 98atom , 97 CP 204633-95-4
  3. Grand View Research: L-Arginine Supplements Market Size & Share Report, 2030
  4. SkyQuest: L-Arginine Market Trends, Size, Share & Forecast | 2031

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.